Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal Adenocarcinoma-Reference-Cited by-同舟云学术

Preclinical Study of AUY922, a Novel Hsp90 Inhibitor, in the Treatment of Esophageal Adenocarcinoma

Published:2016-08 Issue:2 Volume:264 Page:297-304
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Kosovec Juliann E.,Zaidi Ali H.,Kelly Lori A.,Rotoloni Christina L.,Vytlacil Christopher,DiCarlo Christina,Matsui Daisuke,Komatsu Yoshihiro,Boyd Natalie H.,Omstead Ashten,Kolano Elena L.,Biederman Robert W.W.,Finley Gene,Silverman Jan F.,Landreneau Rodney J.,Jobe Blair A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference44 articles.

1. Epidemiology and pathogenesis of esophageal cancer;Holmes;Semin Radiat Oncol,2007

2. Epidemiology of gastroesophageal reflux disease;Rubenstein;Gastroenterol Clin North Am,2014

3. Oesophageal carcinoma;Pennathur;Lancet,2013

4. Cancer statistics, 2015;Siegel;CA Cancer J Clin,2015

5. Esophageal cancer: a review of epidemiology, pathogenesis, staging workup, and treatment modalities;Napier;World J Gastrointest Oncol,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An update on the status of HSP90 inhibitors in cancer clinical trials;Cell Stress and Chaperones;2024-08

2. Sitravatinib combined with PD-1 blockade enhances cytotoxic T-cell infiltration by M2 to M1 tumor macrophage repolarization in esophageal adenocarcinoma;Carcinogenesis;2023-11-29

3. CSF-1R inhibitor, pexidartinib, sensitizes esophageal adenocarcinoma to PD-1 immune checkpoint blockade in a rat model;Carcinogenesis;2022-05-12

4. AUY922 induces retinal toxicity through attenuating TRPM1;Journal of Biomedical Science;2021-07-23

5. Heat-activated nanomedicine formulation improves the anticancer potential of the HSP90 inhibitor luminespib in vitro;Scientific Reports;2021-05-27